Quarterly report pursuant to Section 13 or 15(d)

Common Stock, Preferred Stock and Convertible Preferred Stock (Details)

v3.21.1
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) - USD ($)
 1 Months Ended 3 Months Ended
Feb. 29, 2020
Aug. 31, 2019
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Oct. 31, 2019
Sep. 30, 2019
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Common stock, shares authorized     500,000,000   500,000,000    
Common stock par value (in Dollars per share)     $ 0.0001   $ 0.0001    
Lieu of issuing shares (in Dollars)     $ 3,619        
Preferred stock, shares authorized     10,000,000   10,000,000    
Preferred stock, par value (in Dollars per share)     $ 0.0001   $ 0.0001    
Issued shares of convertible preferred stock     14,804,274        
Exercisable and expire In February 2020, Private Augmedix raised $499,999 in cash proceeds through issuance of 173,752 shares of Series B to certain existing shareholders and warrants to purchase up to 57,338 shares of Series B at a price of $2.88 per share, are immediately exercisable and expire in September 2029. the warrants to purchase shares of Series B were converted to warrants to purchase 2,767,836 shares of common stock at a price of $2.88 per share are immediately exercisable and expire in September 2029.          
Warrants to purchase shares 2,767,836            
Exercise price per share (in Dollars per share) $ 2.88            
Fair value of warrant liability (in Dollars) $ 95,478   $ 170,456      
Common Stock [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Common stock share issued     2,166,667        
Unaccredited Investor [Member[              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Lieu of issuing shares (in Dollars)     $ 555,174        
Majority Shareholder [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Lieu of issuing shares (in Dollars)     $ 10,356        
Series B Preferred Stock [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Cash proceeds (in Dollars) $ 499,999            
Issued shares of convertible preferred stock 173,752            
Warrants to purchase shares 57,338            
Exercise price per share (in Dollars per share) $ 2.88            
Issuance costs (in Dollars) $ 4,017            
Series B Preferred Stock [Member] | Sub Agreement [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Warrants to purchase shares   580,383       57,338 2,130,115